EvidenceHunt, an Amsterdam, Netherlands-based AI-powered medical research platform, has raised €1.2 million in funding.
Investors
The round was led by Keen Venture Partners, Dff.ventures, and Slimmer AI, with participation from notable angel investors, such as Jeroen Tas, Dinko Valerio, and James Shannon.
Keen Venture Partners is a venture capital firm investing in fast-growing European tech companies from seed to Series B. The firm follows a thesis-driven approach, focusing on key technology trends. Its portfolio includes over 30 startups and scale-ups across Europe.
DFF Ventures is an early-stage venture capital fund from Amsterdam that invests in B2B marketplaces, Vertical AI/SaaS, and businesses with network effects. It backs founders across Europe and the MENA region. Since its launch in 2018, DFF has invested in more than 25 companies and manages nearly €100 million in assets.
Slimmer AI is an AI venture studio based in the Netherlands, specializing in developing and co-building AI-powered B2B SaaS companies. It has partnered with Keen Venture Partners and DFF to establish Samen Slimmer, an AI venture alliance supporting European AI startups.
EvidenceHunt Use of Funds
The company will use the funds to extend the platform’s capabilities, enabling teams and organizations to process medical information efficiently.
About the Company
EvidenceHunt is an AI-powered medical research platform designed to help professionals quickly and efficiently pinpoint, analyze, and utilize medical evidence. Users can ask questions and receive clear, summarized answers, complete with cited sources. The platform also offers advanced collaboration features, enabling users to find and share relevant information seamlessly. EvidenceHunt serves a global user base of 25,000 active users, including healthcare professionals, researchers, and students across 90+ countries.
Funding Details
Company: EvidenceHunt
Raised: €1.2M
Round: Unknown
Funding Date: February 2025
Lead Investors: Keen Venture Partners, Dff.ventures, Slimmer AI
Additional Investors: Jeroen Tas, Dinko Valerio, James Shannon
Company Website: https://evidencehunt.com/
Software Category: AI Medical Research
Source: https://evidencehunt.com/blog/aid4v1l7h928hlgno5bmezs2